Literature DB >> 31984163

Reperfusion Injury with Compartment Syndrome Following Systemic Thrombolysis for Cardiac Catheterization-Related Arterial Thrombosis in an Infant.

Dyan Zhewei Zhang1, Teng Hong Tan1, Kenneth Pak Leung Wong2, Sreekanthan Sundaraghavan1, Jonathan Tze Liang Choo1.   

Abstract

Systemic thrombolysis is increasingly used for management of arterial thrombosis following cardiac catheterization, and complications apart from bleeding manifestations are not well reported. We report the case of an infant with lower limb ischemia secondary to femoral arterial thrombosis, which developed after cardiac catheterization. Systemic thrombolysis resulted in successful reperfusion of the lower limb. However, the infant subsequently developed compartment syndrome, requiring an emergent fasciotomy. This case highlights the importance of surveillance for the development of reperfusion injury-related compartment syndrome postsystemic thrombolysis for arterial thrombosis. © Thieme Medical Publishers.

Entities:  

Keywords:  compartment syndrome; reperfusion injury; thrombolysis

Year:  2019        PMID: 31984163      PMCID: PMC6978165          DOI: 10.1055/s-0039-1700522

Source DB:  PubMed          Journal:  J Pediatr Intensive Care        ISSN: 2146-4626


  12 in total

Review 1.  Avoiding reperfusion injury after limb revascularization: experimental observations and recommendations for clinical application.

Authors:  F Beyersdorf; G Matheis; S Krüger; A Hanselmann; H G Freisleben; G Zimmer; P Satter
Journal:  J Vasc Surg       Date:  1989-06       Impact factor: 4.268

Review 2.  Vascular ischaemia and reperfusion injury.

Authors:  Holger K Eltzschig; Charles D Collard
Journal:  Br Med Bull       Date:  2004-10-19       Impact factor: 4.291

Review 3.  Thrombolytic therapy in children.

Authors:  Manuela Albisetti
Journal:  Thromb Res       Date:  2006       Impact factor: 3.944

4.  Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.

Authors:  A A Gupta; M Leaker; M Andrew; P Massicotte; L Liu; L N Benson; B W McCrindle
Journal:  J Pediatr       Date:  2001-11       Impact factor: 4.406

5.  The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children.

Authors:  M D Freed; J F Keane; A Rosenthal
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

6.  Streptokinase treatment for femoral artery thrombosis after arterial cardiac catheterisation in infants and children.

Authors:  F Brus; M Witsenburg; W J Hofhuis; J A Hazelzet; J Hess
Journal:  Br Heart J       Date:  1990-05

7.  Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children.

Authors:  W Zenz; W Muntean; A Beitzke; G Zobel; M Riccabona; A Gamillscheg
Journal:  Br Heart J       Date:  1993-10

8.  Complications associated with pediatric cardiac catheterization.

Authors:  R Vitiello; B W McCrindle; D Nykanen; R M Freedom; L N Benson
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

9.  Tissue Plasminogen Activator Use in Children: Bleeding Complications and Thrombus Resolution.

Authors:  Deidra A Ansah; Kavita N Patel; Leticia Montegna; George T Nicholson; Alexandra C Ehrlich; Christopher J Petit
Journal:  J Pediatr       Date:  2015-12-17       Impact factor: 4.406

10.  Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics.

Authors:  Fiona Newall; Martin Browne; Helen Savoia; Janine Campbell; Chris Barnes; Paul Monagle
Journal:  J Pediatr Hematol Oncol       Date:  2007-04       Impact factor: 1.289

View more
  1 in total

1.  Developing an in-vivo physiological porcine model of inducing acute atraumatic compartment syndrome towards a non-invasive diagnosis using shear wave elastography.

Authors:  Jong Woo Kang; Jong Woong Park; Tae Hyun Lim; Keun Tae Kim; Song Joo Lee
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.